Cited by 500CRISPR and Genetic EngineeringRNA Interference and Gene DeliveryRNA regulation and disease

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing

Open access

Yin, Hao, Song, Chun-Qing, Suresh, Sneha, Wu, Qiongqiong, Walsh, Stephen, Rhym, Luke Hyunsik, Mintzer, Esther, Bolukbasi, Mehmet Fatih, Zhu, Lihua Julie, Kauffman, Kevin, Mou, Haiwei, Oberholzer, Alicia, Ding, Junmei, Kwan, Suet-Yan, Bogorad, Roman L, Zatsepin, Timofei, Koteliansky, Victor, Wolfe, Scot A, Xue, Wen, Langer, Robert, Anderson, Daniel G·2017·Nature Biotechnology

DOI 10.1038/nbt.4005PMC PMC5901668

Open this paper in CoChat — free account

Abstract

Efficient genome editing with Cas9-sgRNA in vivo has required the use of viral delivery systems, which have limitations for clinical applications. Translational efforts to develop other RNA therapeutics have shown that judicious chemical modification of RNAs can improve therapeutic efficacy by reducing susceptibility to nuclease degradation. Guided by the structure of the Cas9-sgRNA complex, we identify regions of sgRNA that can be modified while maintaining or enhancing genome-editing activity, and we develop an optimal set of chemical modifications for in vivo applications. Using lipid nanoparticle formulations of these enhanced sgRNAs (e-sgRNA) and mRNA encoding Cas9, we show that a single intravenous injection into mice induces >80% editing of Pcsk9 in the liver. Serum Pcsk9 is reduced to undetectable levels, and cholesterol levels are significantly lowered about 35% to 40% in animals. This strategy may enable non-viral, Cas9-based genome editing in the liver in clinical settings.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nbt.4005

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Self-citation
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Easy quantitative assessment of genome editing by sequence trace decomposition
Brinkman, E. K., Chen, T., Amendola, M., & van Steensel, B. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku936 · Cited by 2,390

Show all 48 references

Sorted by citations

Items 401–500 of 500

CRISPR-Cas9 engineering of CAR-T cells: Can non-viral nanoparticles unlock safer and scalable genome editing?
My, B., Lia, A., Rizzo, L., Maiorano, G., Galeone, A., Palamà, I. E., & Gigli, G. (2026) · iScience · doi:10.1016/j.isci.2026.115422 · Cited by 2
Synergistic chemical modifications and structural tuning to overcome natural gRNA limitations for next-generation CRISPR biosensors
Zou, G., Liu, X., Li, Y., Li, X., Wang, J., He, X., Zhu, T., & Liu, C. (2026) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2026.118981 · Cited by 2
Delivery Systems for Therapeutic Genome Editing: Challenges, Innovations, and Future Perspectives
Yang, M., Song, Y., Wang, Z., Chao, K., Li, L., Zhang, X., Duan, X., Yu, C., Xue, R., & Zhao, J. (2026) · MedComm · doi:10.1002/mco2.70791 · Cited by 3
Novel Nanotechnology-Based Vector Delivery in CRISPR System for Transgene-Free Editing
Saeed, S., Ahmed, A., Nizamuddin, S., Qureshi, S. S., Shahzad, R., Khan, N. U., Shaban, M., Khan, M. H. U., & Khan, S. U. (2022) · Springer eBooks · doi:10.1007/978-3-030-96925-7_12 · Cited by 2
CRISPR-Cas9 in cancer therapeutics
Randhawa, S. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.016 · Cited by 2
Emerging therapeutic applications of CRISPR genome editing
Qasim, W. (2019) · Emerging Topics in Life Sciences · doi:10.1042/etls20190010 · Cited by 2
Development of Cellular Models to Study Efficiency and Safety of Gene Edition by Homologous Directed Recombination Using the CRISPR/Cas9 System
Sánchez-Hernández, S., Aguilar-González, A., Guijarro-Albaladejo, B., Maldonado‐Pérez, N., Ramos-Hernández, I., Cortijo-Gutierréz, M., Sanchez-Martin, R. M., Benabdellah, K., & Martı́n, F. (2020) · Cells · doi:10.3390/cells9061492 · Cited by 2
Chimeric DNA–RNA Guide RNA Designs
Lu, S., Zhang, Y., & Yin, H. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0687-2_6 · Cited by 2
Self-citation
Advancements of CRISPR/Cas9 technology and its value in antiviral therapeutics
Dev, K., Begum, J., Mir, N. A., & Kant, R. (2021) · Letters In Animal Biology · doi:10.62310/liab.v1i1.60 · Cited by 1
Regulating New Weapon Technologies
Boothby, W. H. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108609388.003 · Cited by 2
Co-opting regulation bypass repair as a gene-correction strategy for monogenic diseases
Hu, J., Bourne, R. A., McGrath, B. C., Lin, A., Pei, Z., & Cavener, D. R. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.017 · Cited by 2
Safe delivery of AAV vectors to the liver of small weaned pigs by ultrasound-guided percutaneous transhepatic portal vein injectionPreprint
Rothgangl, T., Hruzova, M., Gnannt, R., Aeberhard, N., Kissling, L., Grisch‐Chan, H. M., Klassa, S., Rimann, N., Marquart, K. F., Ioannidi, E. I., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.05.535660 · Cited by 2
Advanced drug delivery systems for enhancing the efficacy of RNA-based therapeutics
Alhabib, N. A., Almaniea, M. A., Alehaidib, S. M., Almansour, M. A., Aldosary, M. S., Almegbel, M. T., Alsubaie, S. A., & Alzahrani, A. M. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns10.15029 · Cited by 1
Cleavage efficiency of CRISPR/Cas9 system with G-quadruplex-capped single-guide RNA motifs in RNase II and RNase R
Dang, D. T. (2025) · 3 Biotech · doi:10.1007/s13205-025-04354-x · Cited by 1
Rethinking CRISPR delivery for liver-targeted gene editing: The case for spatially fractionated intra-arterial approaches
Salemdawod, A., Walczak, P., & Janowski, M. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102782 · Cited by 1
Biomedical Potential of Chitosan Nanoparticles: Advances in Drug Delivery and Disease Management
Srinivasan, M. K., Venkatesan, K. B., Jayaseelan, N., & Alamelu, S. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1010092 · Cited by 1
Machine-Learning-Inferred and Energy-Landscape-Guided Analyses Reveal Kinetic Determinants of CRISPR/Cas9 Gene Editing
Jin, L., Liyanage, R., Duan, D., & Chen, S. (2026) · PRX Life · doi:10.1103/rtxh-6fdl · Cited by 1
Aptamer‐Guided CRISPR Systems Delivery: Precision Targeting Strategies, Translational Barriers, and Therapeutic Potential
Ijjeh, Y., Alsarayreh, N., Alqudah, D. A., Elzogheir, N., Abuhaliema, A., Shomali, M. R., Abuarqoub, A. H., Ahmad, M. I., Abdelghany, S. M., Alkilany, A. M., et al. (2026) · Advanced Therapeutics · doi:10.1002/adtp.202500395 · Cited by 1
SORT LNPs encapsulating Cas9 mRNA achieve efficient editing in skeletal muscle in a dystrophic mouse model
Iyer, S. R., Daman, K., Sun, Y., Tutto, A. A., Holbrook, S. E., Joynt, A. T., Yan, J., Ambegaokar, P. P., Guo, D., Liu, P., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.03.010 · Cited by 6
Self-citation
A modified CRISPR/Cas9 approach in silencing the triplication in Down syndrome: A treatment path XISTs
Lian, G., Khabazeh, A., & Sheen, V. L. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2517953123 · Cited by 1
Immune cells in liver injury: from pathogenic mechanisms to immunotherapy
Liao, H., Zhang, J., Zhang, J., 陈亚进, Chen, X., Meng, Y., & Chen, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1770949 · Cited by 1
Montmorillonite in next-generation drug delivery: patent trends, safety insights, and industrial advancements
Asif, A. H., Asha, B. R., Prasanthi, S., Prakash Goudanavar, S. O. P., Prashantha, K., Srikruthi, K. S., Naveen, N. R., Meravanige, G., Shiroorkar, P. N., Swaroop, K., et al. (2026) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-026-07031-4 · Cited by 1
Piperazine-Derived Diamine Lipid Nanoparticles Targeting to the Liver for Delivering Clustered Regularly Interspaced Short Palindromic Repeat Editing of PCSK9 to Durably Maintain Plasmatic Low-Density Lipoprotein Cholesterol in Low Levels
Zhao, S., Huang, S., Li, N., Wang, N., Yu, Z., Liang, X., Yang, Z., & Guo, H. (2026) · ACS Applied Bio Materials · doi:10.1021/acsabm.6c00032 · Cited by 1
VEGFA-Targeted M3-F4 Ionizable Lipid Nanoparticles Improve Diabetic Retinopathy
Liu, S., Bao, Y., Yilihaer, Y., Guo, W., Ma, C., Xue, C., Yang, Z., Chen, Y., & Xie, Z. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6c00026 · Cited by 1
Modalities of vision restoration in optic neuropathies and retinal disease
Rubin, B. R., Lavinsky, F., Cain, R., Kuriyan, A. E., Wollstein, G., Zambrano, R., & Schuman, J. S. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101474 · Cited by 1
Engineering crRNA for CRISPR–Cas12a‐ and Cas13a‐based biosensing: molecular design principles and emerging architectures
Wu, Y., Zhou, S., Ye, X., Zhu, T., Deng, F., & Yang, D. (2026) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2026.118893 · Cited by 1
Precise hepatic base editing of ASGR1 enables robust and durable LDLR-independent lipid lowering in vivo
Hou, Y., Luo, Y., Chen, J., Shang, X., Chang, Y., Zhang, X., Ding, Y., Zhao, W., Ding, C., Feng, X., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.07.036 · Cited by 1
Coumarin linker facilitates regulation of CRISPR/Cas9 activity using visible light
McClain, I. M., Pandit, B., & Royzen, M. (2026) · RSC Advances · doi:10.1039/d6ra04634g · Cited by 1
Single-cell and in vivo profiling reveal heterogeneous and organ-specific CRISPR-Cas9 off-target and translocation outcomes
Madsen, A., Selfjord, N., Martínez-Lage, M., Loyd, A.-L., Kurgan, G., Stahlberg, M., Lindgren, J., Touza, J. L., Wigge, L., Firth, M. A., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-77144-5 · Cited by 2
Dense RNA motif modifications enable robust in vivo prime editing and enhance efficiencies of diverse editing systems
Lei, X., Chen, D., Zhang, K., Liu, X., Chen, Q., Zhang, Y., Ji, R., Zhu, J., Zhang, Q., Zhang, Y., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01787-4 · Cited by 1
Self-citation
Targeted Therapeutic Genome Engineering: Opportunities and Bottlenecks in Medical Translation
Kretzmann, J. A., Luther, D. C., Nörret, M., Rotello, V. M., & Iyer, K. S. (2019) · ACS symposium series · doi:10.1021/bk-2019-1309.ch001 · Cited by 1
Outer Space
de Zwart, M. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108609388.013 · Cited by 1
New ionizable lipids reduce the lipid-to-mRNA ratio for base editing
Gao, S., & Xu, Q. (2024) · National Science Review · doi:10.1093/nsr/nwae224 · Cited by 1
CRISPR-based Technologies for Genome Engineering: Properties, Current Improvements and Applications in Medicine
Geny, S., Hosseini, E. S., Concordet, J., & Giovannangeli, C. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015714-00400 · Cited by 1
Gene Therapy in Liver Disease: Challenges and Outcomes
Premkumar, M., & Singh, V. (2022) · Springer eBooks · doi:10.1007/978-981-16-8845-4_14 · Cited by 1
Aplicación de tecnología de edición de genes como alternativa de tratamiento en pacientes con VIH
Cabrera-Ávila, P., Solano, F. D. C., & Flores-Montesinos, C. (2023) · 593 Digital Publisher CEIT · doi:10.33386/593dp.2023.5.2001
Bio-orthogonal chemistry-based conjugation strategy facilitates investigation of impacts of s 2 U, s 4 U, m 1 A and m 6 A guide RNA modifications on CRISPR activityPreprint
Hoy, A., Zheng, Y. Y., Sheng, J., & Royzen, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.09.495561 · Cited by 1
Single-Stranded DNA with Internal Base Modifications Mediates Highly Efficient Gene Insertion in Primary CellsPreprint
Kanke, K. L., Rayner, R. E., Abel, E., Venugopalan, A., Suu, M., Stack, J. T., Nouri, R., Guo, G., Vetter, T. A., Cormet‐Boyaka, E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.01.578476 · Cited by 1
CRISPR Falling on Deaf Ears
Burgio, G. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.29002.gbu
An optimized toolkit for precision base editingPreprint
Zafra, M. P., Schatoff, E. M., Katti, A., Foronda, M., Breinig, M., Schweitzer, A. Y., Simon, A., Han, T., Goswami, S., Montgomery, E., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/303131
Scissoring genes with light
Ivanov, A. P., & Edel, J. B. (2018) · Nature Chemistry · doi:10.1038/s41557-018-0116-6
So, What Do We Make of All This?
Boothby, W. H. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108609388.016
The Law on the Conduct of Hostilities
Boothby, W. H. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108609388.004
Non-LOAC-Governed Deployment of Military Technologies: Some Regulatory Touchstones
McLaughlin, R. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108609388.005
Synthetic Brain Technologies: Beyond Artificial Intelligence
Fidler, D. P. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108609388.014
Nanomaterials: A Tale of Two Applications
Leins, K., & Bowman, D. M. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108609388.011
Human Degradation Technologies and International Law
Aitken, H., & Nasu, H. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108609388.010
Improving Outcomes in NF1 Spine Fusion
Bobyn, J. D. (2018) · The Sydney eScholarship Repository (The University of Sydney)
Establishment of an efficient genotyping technique based on targeted DNA endonuclease in vitro activity of CRISPR/Cas9 ribonucleoprotein
Wang, N., Qi, X., Liu, C., Xie, C., & Zhu, J. (2020) · ACTA AGRONOMICA SINICA · doi:10.3724/sp.j.1006.2020.93064
Bioanalytical Challenges and Strategies of Crispr Genome Editors
Hölttä, M., Nitsch, R., & Henderson, N. (2021) · Bioanalysis · doi:10.4155/bio-2020-0215
An Analysis of SARS-CoV-2 on the Molecular and Subatomic Levels through Applied I-Theory
Isa, H. H. S., & Dumas, C. (2021) · Advances in Microbiology · doi:10.4236/aim.2021.112006
Therapeutic genome editing
Musunuru, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823484-6.00008-6
CRISPR-Click Enables Multi-Gene Editing with Modular Synthetic sgRNAsPreprint
Park, H., Osman, E. A., Cromwell, C. R., Laurent, C. S., Liu, Y., Kitova, E. N., Klassen, J. S., Hubbard, B. P., Macauley, M. S., & Gibbs, J. M. (2021) · doi:10.33774/chemrxiv-2021-7pdz9
Naval Technologies
von Heinegg, W. H. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108609388.012
Biometrics
Boothby, W. H. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108609388.015
Select Bibliography
Boothby, W. H. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108609388.017
Preface
Boothby, W. H. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108609388.001
Introduction
Boothby, W. H. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108609388.002
Karyotype diversification in colorectal cancer
Bollen, Y. (2022) · doi:10.3990/1.9789036553506
Delivery and Formulation Methods for Therapeutic Genome Editing
Blenke, E. O., & Krishnamurthy, V. R. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch18
DNA Repair Pathways in the Context of Therapeutic Genome Editing
Wimberger, S., Akrap, N., & Taheri‐Ghahfarokhi, A. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch13
Chitin – A Natural Bio‐feedstock and Its Derivatives
Singh, A. T., Jaiswal, S., Kumar, S., & Dutta, P. K. (2022) · doi:10.1002/9781119655749.ch9
Index
Boothby, W. H. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108609388.018
Faculty Opinions recommendation of In vivo CRISPR editing with no detectable genome-wide off-target mutations.
Yip, K. Y.-L. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733997652.793551737
Faculty Opinions recommendation of In vitro Generation of CRISPR-Cas9 Complexes with Covalently Bound Repair Templates for Genome Editing in Mammalian Cells.
Suh, Y. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734902991.793579900
CRISPR/Cas system-guided plasmid mutagenesis without sequence restriction
Zhao, F., Chen, F., Yu, H., Fan, S., Min, B., Xue, J., Zhao, Y., Zuo, X., Fan, C., & Zhao, Y. (2022) · Fundamental Research · doi:10.1016/j.fmre.2022.06.017
Genome Editing with CRISPR‐Cas Systems
Lotfy, P., & Hsu, P. D. (2022) · Wiley eBooks · doi:10.1002/9781683673798.ch11
Non-viral gene editing in utero with lipid nanoparticles complexed to mRNAPreprint
Gao, K., Li, J., Song, H., Han, H., Wang, Y., Yin, B., Farmer, D. L., Murthy, N., & Wang, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.14.512310
Additional file 2 of Engineered circular guide RNAs boost CRISPR/Cas12a- and CRISPR/Cas13d-based DNA and RNA editing
Zhang, X., Wang, X., Lv, J., Huang, H., Wang, J., Ma, Z., Tan, Z., Huang, G., Liu, J., Liu, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23573597
Additional file 1 of Engineered circular guide RNAs boost CRISPR/Cas12a- and CRISPR/Cas13d-based DNA and RNA editing
Zhang, X., Wang, X., Lv, J., Huang, H., Wang, J., Ma, Z., Tan, Z., Huang, G., Liu, J., Liu, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23573594
Additional file 2 of CATI: an efficient gene integration method for rodent and primate embryos by MMEJ suppression
Chen, H., Liu, X., Li, L., Tan, Q., Li, S., Li, L., Li, C., Fu, J., Lu, Y., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23573714
Liposomes as DNA, mRNA and oligonucleotide delivery vectors
Nele, V., Campani, V., & Rosa, G. D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15491-1.00012-2
TERAPIAS CRISPR-CAS9 PARA DOENÇAS GENÉTICAS RARAS: AVANÇOS RECENTES E DESAFIOS
Leite, L. D. A., Gunther, C. B. P., de Vasconcelos, J. O., Maciel, R. N. C., da Silva, M. S., Oliveira, F. D. D. A., Bueno, R. D. C. S., de Melo, T. M. V., Júnior, I. J. D. O., Filho, A. M. D. S., et al. (2024) · Revista Contemporânea · doi:10.56083/rcv4n8-040
CRISPR/Cas9-based genetic engineering for translational research in neurological disorders
Megagiannis, P., Rouleau, G. A., & Zhou, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19041-4.00021-2
Temporal Control of CRISPR-Cas9 Activity Using Bio-orthogonal ChemistryPreprint
Pandit, B., Vangaveti, S., Sentre, J. F., Fuchs, G., & Royzen, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.01.662593
Additional file 1 of Effective control of large deletions after double-strand breaks by homology-directed repair and dsODN insertion
Wen, W., Quan, Z.-J., Li, S.-A., Yang, Z.-X., Fu, Y.-W., Zhang, F., Li, G.-H., Zhao, M., Yin, M.-D., Xu, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15982471
Additional file 1 of Combination gene therapy for HIV using a conditional suicidal gene with CCR5 knockout
Mehmetoglu-Gurbuz, T., Yeh, R., Garg, H., & Joshi, A. (2021) · Figshare · doi:10.6084/m9.figshare.13669378
Additional file 5 of CATI: an efficient gene integration method for rodent and primate embryos by MMEJ suppression
Chen, H., Liu, X., Li, L., Tan, Q., Li, S., Li, L., Li, C., Fu, J., Lu, Y., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23573735
Additional file 1 of CATI: an efficient gene integration method for rodent and primate embryos by MMEJ suppression
Chen, H., Liu, X., Li, L., Tan, Q., Li, S., Li, L., Li, C., Fu, J., Lu, Y., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23573711
Additional file 4 of CATI: an efficient gene integration method for rodent and primate embryos by MMEJ suppression
Chen, H., Liu, X., Li, L., Tan, Q., Li, S., Li, L., Li, C., Fu, J., Lu, Y., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23573729
Additional file 3 of Engineered circular guide RNAs boost CRISPR/Cas12a- and CRISPR/Cas13d-based DNA and RNA editing
Zhang, X., Wang, X., Lv, J., Huang, H., Wang, J., Zhuo, M., Tan, Z., Huang, G., Liu, J., Liu, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23573600
Additional file 6 of CATI: an efficient gene integration method for rodent and primate embryos by MMEJ suppression
Chen, H., Liu, X., Li, L., Tan, Q., Li, S., Li, L., Li, C., Fu, J., Lu, Y., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23573741
Additional file 3 of CATI: an efficient gene integration method for rodent and primate embryos by MMEJ suppression
Chen, H., Liu, X., Li, L., Tan, Q., Li, S., Li, L., Li, C., Fu, J., Lu, Y., Wang, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23573723
Additional file 2 of Effective control of large deletions after double-strand breaks by homology-directed repair and dsODN insertion
Wen, W., Quan, Z.-J., Li, S.-A., Yang, Z.-X., Fu, Y.-W., Zhang, F., Li, G.-H., Zhao, M., Yin, M.-D., Xu, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15982474
A guide RNA repeat checkpoint steers CRISPR-Cas9 catalysisPreprint
Chilamkurthy, R., Sudhakar, S., Pater, A. A., Bosmeny, M. S., Stabile, F., Katolik, A., Harikrishna, S., Turk, R., Damha, M. J., Leslie, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.02.691602
Bio-orthogonal chemistry-based strategy to Turn-OFF CRISPR-Cas9 activity in solution and live cells
Pandit, B., Vangaveti, S., Sentre, J. F., McClain, I. M., Fuchs, G., & Royzen, M. (2026) · NAR Molecular Medicine · doi:10.1093/narmme/ugag008
Evolution and advancements of techniques in generating transgenic animals: From random integration to targeted precision
Wadhwa, N., Ghorai, S. M., Bajaj, D., Singh, S., & Datta, S. (2026) · Next research. · doi:10.1016/j.nexres.2026.101470
Fast mRNA delivery in vitro and in vivo enabled by magnetic responsive lipid nanoparticles
Lin, Y., Wu, J., Liu, Z., Song, R., Li, Z., Zhang, R., & Li, B. (2026) · Advanced Composites and Hybrid Materials · doi:10.1007/s42114-026-01690-1
Fully Modified SpyCas9 Guide RNAs Enable Robust Genome Editing In Cells and In VivoPreprint
Vu, K. A., Zhang, H., Amrani, N., Devi, G., Gaston, N., Lee, J., Maitland, S. A., Chen, Z., Echeverria, D., Liu, P., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.28.725424
Self-citation
Inducible CRISPR/Cas systems in precision oncology: Current applications and future perspectives
Ding, Z., Wei, Y., Han, Y. P., & Gu, P. (2026) · Clinical and Translational Medicine · doi:10.1002/ctm2.70720
CRISPR RNA architecture steers Cas9 catalysis and fidelity via a guide repeat clasp motif
Chilamkurthy, R., Sudhakar, S., Pater, A. A., Bosmeny, M. S., Stabile, F., Katolik, A., Harikrishna, S., Elazzouzi, F., Turk, R., Damha, M. J., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag710
Cas12a chRDNA-mediated in vivo genome editing for high specificity functional gene disruption
Losa, M., Rajmane, P., Stanaway, M., Coons, M., Munoz, A., Garish, V., Tan, B., Thompson, M., Gonzalez, R., Churchward, G., et al. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.103084 · Cited by 1
Enhanced CRISPR-Cas3-mediated genome editing using circularized crRNAs
Mikamo, K., Yoshimi, K., Abe, H., Takeshita, K., Abe, H., & Mashimo, T. (2026) · iScience · doi:10.1016/j.isci.2026.117481
Navigating off-target effects in CRISPR-based genome editing for safer gene therapies
Bhardwaj, A. (2026) · Discover Genetics and Evolution · doi:10.1007/s00294-026-01339-y
Advancements in CRISPR-based in vivo gene therapy for hemophilia
Zhang, X., Xu, K., Zou, S., Zhu, Z., Teng, S., & Huang, P. (2026) · Frontiers in Genome Editing · doi:10.3389/fgeed.2026.1924733
Overcoming delivery barriers of large all-in-one CRISPR/Cas9 plasmids using lysine-based lipid nanoparticles
Sung, W., Li, T., & Takeoka, S. (2026) · Frontiers in Genome Editing · doi:10.3389/fgeed.2026.1888079
RNA therapeutics: current status and future directions
Yang, B., Sedano, M. J., Perez, K. L., Vijayaraghavan, M., Reid, V. A., Yallapu, M. M., Chauhan, S. C., Dhandayuthapani, S., Ramos, E., & Gadad, S. S. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-03032-5 · Cited by 1
CRISPR-Based Genome Editing and Delivery Systems: Advances, Challenges and Future Directions
Kaur, A., Chanan, R., Sharma, M., Sharma, S., & Sharma, D. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1016405
Chromatin Modifications Orchestrate DNA Repair Pathway Choice: Epigenetics Strategies for Enhancing CRISPR –Cas9‐Mediated Knock‐In Efficiency
Chen, X., Qin, S., Yang, C., Xing, Z., Liu, C., Zhang, X., Wu, X., Li, X., Gong, Y., & Liu, Z. (2026) · Cell Proliferation · doi:10.1111/cpr.70285
Reversible genome editing
Zhang, H.-X., Duan, J., Qiubing, C., 林, 磊., Zhang, Y., Duan, M., Chen, D., Liu, X., Wu, L., Wang, G., et al. (2026) · Vita · doi:10.15302/vita.2026.09.0074
Self-citation

Authors: Yin, H., Song, C.-Q., Suresh, S., Wu, Q., Walsh, S., Rhym, L. H., Mintzer, E., Bolukbasi, M. F., Zhu, L. J., Kauffman, K., Mou, H., Oberholzer, A., Ding, J., Kwan, S.-Y., Bogorad, R. L., Zatsepin, T., Koteliansky, V., Wolfe, S. A., Xue, W., Langer, R., & Anderson, D. G.
Affiliations: Koch Institute for Integrative Cancer Research At MIT (US)
University of Massachusetts Chan Medical School (US)
Skolkovo Institute of Science and Technology (RU)
Harvard–MIT Division of Health Sciences and Technology (US)
Corresponding author: Anderson, Daniel G
ORCID: Yin, Hao
Song, Chun-Qing
Suresh, Sneha
Walsh, Stephen
Rhym, Luke Hyunsik
Mintzer, Esther
Bolukbasi, Mehmet Fatih
Zhu, Lihua Julie
Kauffman, Kevin
Mou, Haiwei
Bogorad, Roman L
Zatsepin, Timofei
Wolfe, Scot A
Xue, Wen
Anderson, Daniel G
Venue: Nature Biotechnology
Publisher: Springer Science and Business Media LLC
Published: 2017-11-13
Volume: 35
Issue: 12
Pages: 1179-1187
ISSN: 0733-222X (ISSN-L)
1087-0156
1546-1696
DOI: 10.1038/nbt.4005
PMC: PMC5901668
OpenAlex: W2770127492
Cited by: 499
References: 48
Citations by year: 2026: 39 · 2025: 31 · 2024: 53 · 2023: 63 · 2022: 75 · 2021: 64 · 2020: 52 · 2019: 51 · 2018: 71
FWCI: 19.43
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: www.springer.com/tdm (tdm)
Locations: Nature Biotechnology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
Funders: Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
Skolkovo Institute of Science and Technology
National Institutes of Health
National Heart, Lung, and Blood Institute (P01HL131471, DP2HL137167)
National Cancer Institute (U54CA151884, R00CA169512, P30CA014051)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Keywords: Cas9, in vivo gene editing, non-viral delivery, lipid nanoparticle delivery, PCSK9, cholesterol lowering, RNA therapeutics, nuclease resistance
MeSH terms: Proprotein Convertase 9, Gene Editing, RNA, Guide, CRISPR-Cas Systems, Animals, Liver, Nucleic Acid Conformation, Gene Transfer Techniques, Mice, Nanoparticles, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks